Health
Rich nations snap up vaccine stocks in global race for jab
Rich nations representing a fraction of the global population have already bought up over half the promised Covid-19 vaccine stocks, a study ...Turkey begins Phase III trials of Chinese coronavirus vaccine
Turkey began final Phase III trials of an experimental Chinese coronavirus vaccine on Wednesday, Turkish media reported. The vaccine will be administered ...Russia to sell 100 million doses of COVID-19 vaccine to India
Russia’s sovereign wealth fund said on Wednesday it will supply India’s Dr. Reddy’s Laboratories with 100 million doses of the Sputnik-V vaccine ...China coronavirus vaccine may be ready for public in November
Coronavirus vaccines being developed in China may be ready for use by the general public as early as November, an official with ...WHO head urges rich nations to join vaccine scheme by Friday deadline
Countries should join the World Health Organization’s (WHO) COVAX vaccine facility by a Friday deadline to help ensure that immunizations are fairly ...Vaccine trial resumes as virus continues grim march
Clinical trials of one of the most advanced experimental Covid-19 vaccines resumed Saturday after a brief safety pause, as infection numbers continued ...Crowds rally in New Zealand’s Auckland against coronavirus lockdown
Large crowds of people rallied in Auckland on Saturday against the government’s social distancing restrictions imposed on the country’s largest city after ...AstraZeneca suspends leading COVID-19 vaccine trials after a participant’s illness
AstraZeneca Plc said it has paused global trials, including large late-stage trials, of its experimental coronavirus vaccine due to an unexplained illness ...U.S., European COVID vaccine developers pledge to uphold testing rigour
Nine leading U.S. and European vaccine developers pledged on Tuesday to uphold the scientific standards their experimental immunisations will be held against ...Russia completes early trials of second potential COVID-19 vaccine: Ifax
Siberia’s Vector virology institute on Tuesday completed early-stage human trials, known as Phase II, of a second potential Russian vaccine against COVID-19, ...














